Sign in

    Crane Co (CR)

    Q4 2024 Summary

    Published Feb 18, 2025, 5:23 PM UTC
    Initial Price$158.00October 1, 2024
    Final Price$151.75December 31, 2024
    Price Change$-6.25
    % Change-3.96%
    • Crane Co. has a strong backlog in its Process Flow Technologies (PFT) segment, which is approximately 40% higher than in 2019, demonstrating strong demand and excellent execution. They are confident in achieving their guidance of low to mid-single-digit growth in 2025.
    • The company is benefiting from strong demand in their new cryogenics business, with continued projects in upgrades, efficiency improvements, and capacity expansions in chemical, pharmaceutical, and other vertical markets, and they expect some improvement as they go into 2025.
    • Crane Co. has significantly shifted its PFT portfolio towards higher-growth markets, increasing from around 30% in 2017 to over 60% now, aiming to reach 70% in the midterm, indicating continued potential for margin expansion and profitable growth.
    • The Process Flow Technologies (PFT) segment experienced a backlog reduction in the second half of the year, potentially indicating a slowdown in demand or future sales growth.
    • Management noted that Europe and China were deteriorating or stagnant markets, which could negatively affect the company's growth in those regions.
    • There are concerns about exposure to geopolitical risks in China for PFT programs if aggressive tariffs and potential retaliation occur, which could impact the company's performance.
    MetricYoY ChangeReason

    Total Revenue

    –27% (from $532.9M to $387.5M)

    A significant decline of 27% is observed, which likely reflects the impact of restructuring, divestitures, and a changed revenue mix compared to the prior period, despite other segments showing healthy momentum.

    Aerospace & Electronics

    +11% (from $212.8M to $236.8M)

    Strong underlying demand and incremental pricing improvements drove an 11% rise, consistent with historical trends in the segment which previously benefited from robust commercial and defense market conditions.

    Commercial OE

    +9.5% (from $77.4M to $84.8M)

    Robust recovery in the aerospace sector along with the positive impact of the Vian acquisition boosted Commercial OE sales by 9.5%, a continuation of trends seen in earlier periods.

    Military Aftermarket

    +37% (from $19.1M to $26.1M)

    A dramatic 37% increase is primarily driven by heightened military demand amid evolving geopolitical tensions, a trend that intensified compared to previous periods.

    Commercial Aftermarket

    +15% (from $53.0M to $61.1M)

    Improved airline demand and continued inventory restocking fuelled a 15% increase, reflecting a sustained recovery in air travel similar to past performance.

    Process Flow Technologies

    +13% (from $271.5M to $307.3M)

    Core sales growth enhanced by better pricing and productivity gains resulted in a 13% increase, mirroring earlier period improvements and strategic execution in this segment.

    Process Valves

    +11% (from $213.7M to $237.6M)

    Sales increased by 11% driven by acquisitions (BAUM and CryoWorks) and invigorated core sales with higher pricing in key end markets, continuing a growth trajectory noted in previous periods.

    Commercial Valves

    +34% (from $25.8M to $34.5M)

    A substantial 34% increase is attributable to strong core sales driven by volume and pricing improvements as well as favorable foreign exchange, consistent with recent trends.

    Pumps and Systems

    +10% (from $32.0M to $35.2M)

    A 10% growth was achieved through overall market strength and overcoming previous cost challenges, underscoring improved performance compared to the prior period.

    TopicPrevious MentionsCurrent PeriodTrend

    Process Flow Technologies

    In Q1–Q3, PFT was discussed in terms of steady demand, backlog growth (Q1: strong in North America and China with softness in Europe ; Q2: strong demand and margin expansion ; Q3: consistent order rates and significant margin improvement )

    In Q4, PFT continues its steady demand story with a slightly lower second‐half backlog due to shipment timing and robust margin expansion (20.3% with plans to further improve)

    Sustained performance with continued margin expansion and stable demand trends.

    Portfolio Shift

    Q3 and Q2 emphasized a shift toward higher–growth, higher–margin markets (with references to structural margin improvements ). In Q1, moves were implicit via acquisitions (e.g. CryoWorks ).

    Q4 explicitly details a strategic focus to increase the portfolio mix from around 30% to over 60% (with a target of 70% midterm)

    An increased explicit focus with clear medium–term targets for transitioning toward higher–margin markets.

    Cryogenics Business

    Mentioned in Q1 through the acquisition of CryoWorks as a strategic entry (driving high–growth market access ); in Q2 and Q3, growth potential was highlighted with significant orders and smaller acquisitions ( , , ).

    In Q4, cryogenics is portrayed as a key growth driver with strong demand and strategic acquisitions (adding roughly $55 million in revenue)

    A growing pillar with robust demand and increasing strategic investment, reinforcing its importance for future growth.

    M&A Activity

    Throughout Q1–Q3, robust pipelines were noted—Q1 featured the CryoWorks deal , Q2 discussed over $1 billion capacity with a mix of small-to-midsize transactions , and Q3 emphasized an active pipeline targeting the cryogenics space and larger opportunities.

    Q4 stresses an even more active M&A pipeline and increased capacity (approximately $1.5 billion available), with clear intent to drive accelerated inorganic growth in 2025

    Consistently strong activity with an increasing focus on leveraging financial capacity to accelerate future growth.

    Regional Challenges

    In Q1, European markets were weak while China showed resilience due to localization and cyclical recovery ; Q2 noted softness in Europe but some strength in China ; Q3 reinforced persistent challenges in Europe and China.

    In Q4, Europe and China are described as stagnant but stable, with improvement potential in 2025

    Persistent challenges, especially in Europe, though stabilization in China suggests modest improvement prospects.

    Global Macroeconomic & Geopolitical Risks

    Q1 highlighted significant uncertainty from geopolitical tensions, inflation, and political risks ; Q3 included general preparedness for external shocks ; Q2 did not feature explicit discussion.

    Q4 does not explicitly emphasize these risks, aside from noting mixed industrial signals, implying a reduced spotlight on these issues

    A shift from explicit concern in earlier quarters to a relatively muted discussion in Q4, though external risks remain an underlying factor.

    Natural Disaster Impact

    Q3 discussed Hurricane Helene causing a $0.03 EPS drag and forecast a Q4 impact of $0.05–$0.10 EPS, with recovery proceedings extending into 2025 ; Q1 and Q2 did not discuss these impacts.

    Q4 provides detailed emphasis on a $0.09 EPS impact from production downtime (at the higher end of expectations) and notes that the insurance recovery is delayed into Q2/Q3 2025

    An increased focus on natural disaster risks with detailed tracking of short–term profitability impacts and delayed recoveries.

    Order Dynamics

    In Q2, positive order activity was noted alongside a sequential decrease in backlog (a 1% drop) due to project timing ; little mention in Q1 and Q3.

    Q4 reiterates sequentially consistent order trends despite a reduction in H2 backlog due to project booking and shipment timing

    Consistent order trends with timing–based fluctuations impacting backlog figures.

    Aerospace & Electronics Sentiment

    Q1 showed a positive yet cautious tone due to external uncertainties and strong project wins ; Q2 presented a mix of strong wins with supply chain caution ; Q3 was very positive with robust backlog growth and significant project wins.

    Q4 sentiment is strong and optimistic, with record backlog levels ($864 million), significant project wins (e.g. a $44 million order for an F–16 upgrade), and high growth projections for 2025

    An overall improvement in confidence, with robust project wins increasingly overshadowing earlier caution.

    Pricing Strategy

    Q1 focused on disciplined and assertive pricing (contributing mid–single–digit growth in PFT and about one–third of growth in A&E ); Q2 confirmed steady contributions from pricing in both segments ; Q3 highlighted enhanced value–pricing initiatives and operational excellence.

    Q4 underscores a strong value–pricing strategy that not only offsets inflation but also drives revenue growth, contributing to an 8% core sales growth and significant margin expansion

    Consistently successful and increasingly refined, with pricing strategy evolving to drive greater revenue and margin benefits over time.